Sorafenib/ Carboplatin/ Paclitaxel in Patients With Solid Tumors

NCT00606125 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Nexavar (Sorafenib, BAY43-9006)

Sponsor

Bayer